Cited in:


This article has been cited by:

  1. 1
    Matthew S. Karafin, Bruce S. Sachais, Laura Connelly-Smith, Joshua J. Field, Michael L. Linenberger, Anand Padmanabhan, NHLBI state of the science symposium in therapeutic apheresis: Knowledge gaps and research opportunities in the area of hematology-oncology, Journal of Clinical Apheresis, 2016, 31, 1
  2. 2
    Alfia Khaibullina, Luis E.F. Almeida, Li Wang, Sayuri Kamimura, Edward C.C. Wong, Mehdi Nouraie, Irina Maric, Sarah Albani, Julia Finkel, Zenaide M.N. Quezado, Rapamycin increases fetal hemoglobin and ameliorates the nociception phenotype in sickle cell mice, Blood Cells, Molecules, and Diseases, 2015, 55, 4, 363


  3. 3
    Carlton Dampier, Beth Ely, Darcy Brodecki, Camille Coleman, Leela Aertker, Jocelyn Andrel Sendecki, Benjamin Leiby, Karen Kesler, Terry Hyslop, Marie Stuart, Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease, Pediatric Blood & Cancer, 2014, 61, 2
  4. 4
    Wally R. Smith, Treating Pain in Sickle Cell Disease with Opioids: Clinical Advances, Ethical Pitfalls, The Journal of Law, Medicine & Ethics, 2014, 42, 2
  5. 5
    STEPHEN H. EMBURY, Can Pain Studies Influence Regulatory Policy?, Pain Medicine, 2011, 12, 5